2020-05-26T11:35:50+00:00

WHO suspends clinical test for malaria drug hydroxychloroquine

Credit: Marcelo Casal/Agencia Brasil

The World Health Organization (WHO) has stopped a clinical trial for hydroxychloroquine due to safety concerns after a paper published in The Lancet showed that people taking the drug were at higher risk of death and heart problems than those that were not.

During a news briefing WHO director-general, Tedros Adhanom Ghebreyesus, stated "This concern relates to the use of hydroxychloroquine and chloroquine in Covid-19,"

Sources: Content Sources

Source: Deutsche Welle

Source: upi.com

Image Source

Marcelo Casal/Agencia Brasil

Pentributor:

Érico Andrei

@ericof

Co-founder of Pendect, passionate about open source and knowledge sharing. Made in Mooca.

Card reviewed by: @christoph

Categorization:

Organizations & Institutions

World Health Organization

Public Figures & People

Tedros Adhanom

Cookies🍪

Our website uses scripts, such as cookies, to technically provide the site ("essential scripts") and third-party website tracking technologies to provide and continually improve our services and display advertisements based on the perceived interests of users. By clicking the "Accept All" button, the website visitor agrees to the activation of all scripts. Essential cookies are also executed without the consent. The consent can be revoked or changed at any time with effect for the future. By clicking the "Reject" button, only essential cookies are used. In our data protection policy, we provide detailed information about the type and scope of data processing.

Accept All Reject